DK0791056T3 - Lipid cleavage enzyme complex - Google Patents

Lipid cleavage enzyme complex

Info

Publication number
DK0791056T3
DK0791056T3 DK95937058T DK95937058T DK0791056T3 DK 0791056 T3 DK0791056 T3 DK 0791056T3 DK 95937058 T DK95937058 T DK 95937058T DK 95937058 T DK95937058 T DK 95937058T DK 0791056 T3 DK0791056 T3 DK 0791056T3
Authority
DK
Denmark
Prior art keywords
enzyme
substrates
enzyme complex
cleavage enzyme
disclosed
Prior art date
Application number
DK95937058T
Other languages
Danish (da)
Inventor
Hans-Georg Opitz
Harald Zilch
Dieter Herrmann
Original Assignee
Heidelberg Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19518278A external-priority patent/DE19518278A1/en
Application filed by Heidelberg Pharma Gmbh filed Critical Heidelberg Pharma Gmbh
Application granted granted Critical
Publication of DK0791056T3 publication Critical patent/DK0791056T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)

Abstract

A membranous enzyme not yet described in the state-of-the-art can be extracted from cellular membrane fractions of blood leukocytes or monocytes/macrophages. Also disclosed is the use of substrates of this enzyme to prepare medicaments that contain these substrates as pharmaceutical active substance. These medicaments are useful to direct pharmacologically active substances to target cells and to enrich target cells with said substances. Also disclosed are in-vitro research systems containing this enzyme used to detect other substrates of this enzyme.
DK95937058T 1994-11-12 1995-11-09 Lipid cleavage enzyme complex DK0791056T3 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE4440472 1994-11-12
DE19518278A DE19518278A1 (en) 1994-11-12 1995-05-18 Lipid-cleaving enzyme
PCT/EP1995/004414 WO1996015234A2 (en) 1994-11-12 1995-11-09 Lipid-splitting enzyme

Publications (1)

Publication Number Publication Date
DK0791056T3 true DK0791056T3 (en) 2005-07-04

Family

ID=25941931

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95937058T DK0791056T3 (en) 1994-11-12 1995-11-09 Lipid cleavage enzyme complex

Country Status (12)

Country Link
EP (1) EP0791056B1 (en)
JP (2) JP3681005B2 (en)
AT (1) ATE292173T1 (en)
AU (1) AU711367B2 (en)
CA (1) CA2204908A1 (en)
DE (1) DE59510996D1 (en)
DK (1) DK0791056T3 (en)
ES (1) ES2239761T3 (en)
HU (1) HUT77486A (en)
NZ (1) NZ295682A (en)
PT (1) PT791056E (en)
WO (1) WO1996015234A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE50102334D1 (en) 2000-03-31 2004-06-24 Stockhausen Chem Fab Gmbh POWDERED POLYMERISATE CROSSLINED ON THE SURFACE
EP1460082A1 (en) * 2003-03-19 2004-09-22 Heidelberg Pharma Holding GmbH Phospholipid esters of clofarabine derivatives
WO2008052722A2 (en) * 2006-11-02 2008-05-08 Heidelberg Pharma Ag Use of ribavirin-conjugates as an anti-viral drug
EP2070938A1 (en) * 2007-12-13 2009-06-17 Heidelberg Pharma AG Clofarabine dietherphospholipid derivatives
EP4351353A1 (en) * 2021-06-07 2024-04-17 Campbell, M.E., B.E., Farida Hanna Multi-virus anti-infectivity and pro-immunity assembly

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4026265A1 (en) * 1990-08-20 1992-02-27 Boehringer Mannheim Gmbh NEW PHOSPHOLIPID DERIVATIVES OF NUCLEOSIDES, THEIR PRODUCTION AND THEIR USE AS ANTIVIRAL MEDICINAL PRODUCTS
DE4402492A1 (en) * 1994-01-28 1995-08-03 Boehringer Mannheim Gmbh Process for the production of asymmetrical phosphoric acid diesters

Also Published As

Publication number Publication date
EP0791056A2 (en) 1997-08-27
WO1996015234A2 (en) 1996-05-23
AU711367B2 (en) 1999-10-14
CA2204908A1 (en) 1996-05-23
AU3927895A (en) 1996-06-06
JPH10508498A (en) 1998-08-25
JP3681005B2 (en) 2005-08-10
WO1996015234A3 (en) 1996-06-20
NZ295682A (en) 1999-09-29
HUT77486A (en) 1998-05-28
JP2005095178A (en) 2005-04-14
ES2239761T3 (en) 2005-10-01
ATE292173T1 (en) 2005-04-15
PT791056E (en) 2005-08-31
EP0791056B1 (en) 2005-03-30
DE59510996D1 (en) 2005-05-04

Similar Documents

Publication Publication Date Title
Ortega‐Gómez et al. Resolution of inflammation: an integrated view
Strickland et al. Studies on the role of plasminogen activator in ovulation. In vitro response of granulosa cells to gonadotropins, cyclic nucleotides, and prostaglandins.
Mizel et al. Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1).
Unanue et al. Regulation of immunity and inflammation by mediators from macrophages.
Ward Leukotactic factors in health and disease
McCARTHY et al. Mediation of macrophage collagenase production by 3'-5'cyclic adenosine monophosphate.
Sadique et al. The anti-inflammatory activity of Enicostemma littorale and Mollugo cerviana
ATE397665T1 (en) LYMPHOTOXIN-BETA, LYMPHOTOXIN-BETA COMPLEXES, PHARMACEUTICAL PREPARATIONS AND THERAPEUTIC USES THEREOF
ATE208632T1 (en) PHOSPHOLIPIDE ADMINISTRATION SYSTEM
ATE218365T1 (en) STABILIZED FIBRINOGEN-BASED MIXTURE
Li et al. Enhancement by neutrophils of collagen degradation by corneal fibroblasts
Smith et al. Pharmacological modulation of chemotactic factor-elicited release of granule-associated enzymes from human neutrophils: Effects of prostaglandins, nonsteroid anti-inflammatory agents and corticosteroids
DK0791056T3 (en) Lipid cleavage enzyme complex
Class et al. Histone H1 suppresses tumor growth of leukemia cells in vitro, ex vivo and in an animal model suggesting extracellular functions of histones
Barnes Platelets in glomerular disease
Eisen Plasma kinins in synovial exudates
DE69528170D1 (en) INTRACELLULAR ADMINISTRATION OF THERAPEUTIC SUBSTANCES VIROSOMES
ES2004099A6 (en) Use of biologically active polypeptides and compositions containing them.
Dessaint et al. Catheptic Carboxypeptidase B as A Major Componekt in “T-Cell Activating Factor” of Macrophages
Ragsdale et al. Characteristics of fibrinolytic enzyme release from human monocytes.
ES2145284T3 (en) DERIVATIVES OF DIOXO-TIOPIRANO-PIRIDIN-CARBOXILICO ACID AND ITS USE AS DRUGS.
Schwartz Enzyme mediators of mast cells and basophils
De Jong et al. The inter‐relation between inflammation and epidermal proliferation in normal skin following epicutaneous application of leukotriene‐B4—an immunohistochemical study
SE8601563D0 (en) MATERIAL MATERIAL, PROCEDURES FOR PREPARING IT AND USING IT
BR9611588A (en) Use of flupirtine in the prophylaxis and therapy of diseases associated with damage to the hematopoietic cellular system